Mountain Crest Acquisition Corp II

closed

BTTXSEC EDGARCIK: 0001832415|Mountain Crest Capital LLC

Capital Structure & Economics

Trust Size$50,000,000

Unit Price$0.19

Warrant Coverage-

Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

No Warrants / No Drag

Public Trust Allocation	$50,000,000
Sponsor At-Risk Capital	N/A
Total Underwriting Discount	N/A
Trust Per Unit (Implied)	$0.19
Sponsor Promote Allocation	20%

Deal Lifecycle

IPO PricedDec 21, 2020

SearchingTarget Pending

Maturation Wall

N/A

Announced Target / M&A

Target CompanyBetter Therapeutics, Inc.
Announced Deal Size$150,000,000

Board & Officers

Frank KarbeCEO
Chardan Capital Markets, LLC⁽⁸⁾Officer
Suying Liu⁽⁶⁾
Officer
Dong Liu⁽²⁾
Officer
David PerryDirector
Dr. Mark BermanDirector
Kristin WynholdsDirector
Dr. Richard CarmonaDirector
Andrew ArmaninoDirector
Geoffrey ParkerDirector
Dr. Risa Lavizzo-MoureyDirector
Dr. Elder GrangerDirector
Nelson Haight⁽⁶⁾
Director
Todd Milbourn⁽⁶⁾
Director
Wenhua Zhang⁽⁶⁾
Director

Syndicate & Advisors

Chardan Capital Markets, LLC
LEAD
B. Riley Securities, Inc.
LEAD

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction